( OTC-BB:CTSO )

News from CytoSorbents Corporation A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Dec 02, 2016, 08:00 ET CytoSorbents to Present at the LD Micro Main Event Investor Conference

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its European Union approved CytoSorb® cytokine...


Dec 01, 2016, 07:15 ET CytoSorb® Selected for NICE MedTech Innovation Briefing in the United Kingdom

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its European Union approved CytoSorb® cytokine...


Nov 22, 2016, 08:20 ET First Successful Treatment of Dengue Fever and Dengue Shock Syndrome Using CytoSorb®

CytoSorbents Corporation (NASDAQ: CTSO), highlights the first successful treatment of Dengue Shock Syndrome caused by Dengue virus infection using...


Nov 17, 2016, 08:00 ET CytoSorbents Reports Highlights from the SepsEast 2016 Critical Care Congress

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its European Union approved CytoSorb® cytokine...


Nov 15, 2016, 08:00 ET Adrian Thomas Joins CytoSorbents to Drive Western European Sales

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its European Union approved CytoSorb® cytokine...


Nov 07, 2016, 16:15 ET CytoSorb® Q3 2016 Sales Reach Record $2.14M, Doubling From a Year Ago

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its flagship CytoSorb® cytokine adsorber to prevent...


Nov 03, 2016, 08:00 ET CytoSorbents Expands Direct Sales of CytoSorb to Belgium and Luxembourg

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its flagship CytoSorb® extracorporeal cytokine...


Nov 01, 2016, 07:00 ET CytoSorbents to Report Q3 2016 Operating and Financial Results

CytoSorbents Corporation (CTSO), a critical care immunotherapy leader commercializing its flagship CytoSorb® extracorporeal cytokine adsorber to...


Oct 17, 2016, 07:00 ET CytoSorbents Congratulates Kathleen Bloch as NJBIZ Public Company Chief Financial Officer of the Year

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its flagship CytoSorb® extracorporeal cytokine...


Oct 14, 2016, 07:00 ET CytoSorbents to Present at the 2016 BIO Investor Forum

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its flagship CytoSorb® extracorporeal cytokine...


Oct 11, 2016, 08:00 ET CytoSorbents and Foxx Medical Begin Saving Lives in Chile with CytoSorb®

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its flagship CytoSorb® cytokine adsorber to treat...


Oct 05, 2016, 07:00 ET CytoSorbents Announces Positive Top-line Safety Data from REFRESH I Cardiac Surgery Trial

 CytoSorbents Corporation (NASDAQ: CTSO), a therapeutic device company commercializing its CytoSorb® blood purification cartridge to...


Oct 03, 2016, 07:00 ET Auftakt für internationale Vermarktung von CytoSorb® auf Konferenz der Europäischen Gesellschaft für Herz- und Thorax-Chirurgie

Hochkarätige Marketing-Events bieten vielfältige Möglichkeiten, CytoSorb Herzchirurgen und Kardiotechnikern in ganz Europa...


Oct 03, 2016, 07:00 ET Le marketing international de CytoSorb® commence dans le cadre de la conférence de l'Association européenne de chirurgie cardio-thoracique

Des évènements de marketing très médiatisés fourniront de multiple occasions de présenter CytoSorb aux chirurgiens et...


Oct 03, 2016, 07:00 ET Comienza la comercialización internacional de CytoSorb®

- Comienza la comercialización internacional de CytoSorb® en la conferencia de la European Association for Cardio-Thoracic...


Oct 03, 2016, 07:00 ET International Marketing of CytoSorb® Commences at European Association for Cardio-Thoracic Surgery Conference

 CytoSorbents Corporation (NASDAQ: CTSO), manufacturer of the CytoSorb® extracorporeal cytokine adsorber that targets the reduction of...


Sep 29, 2016, 08:30 ET New CytoSorbents Website Highlights Global Growth and Innovation

CytoSorbents Corporation (NASDAQ: CTSO) a critical care immunotherapy company working to save lives through blood purification, announced the...


Sep 23, 2016, 08:30 ET CytoSorbents Expands CytoSorb® into Iran with Partner Arsak

 CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its flagship CytoSorb® cytokine adsorber to...


Sep 15, 2016, 08:00 ET CytoSorbents Sponsors Sepsis Heroes Gala in Honor of World Sepsis Day

CytoSorbents Corporation (NASDAQ: CTSO), a leader in critical care immunotherapy using its CytoSorb® blood purification technology to help...


Sep 08, 2016, 07:00 ET CytoSorbents Advances War On Sepsis with Development of CytoSorb-XL

CytoSorbents Corporation (NASDAQ: CTSO), commercializing its European Union approved CytoSorb® blood purification cartridge to reduce deadly...


Sep 07, 2016, 07:00 ET CytoSorbents to Present at the 2016 Rodman & Renshaw Annual Global Investment Conference

 CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its flagship CytoSorb® blood filter to...


Aug 09, 2016, 16:15 ET CytoSorbents Achieves Fourth Consecutive Quarter of Record CytoSorb® Sales

 CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its flagship CytoSorb® blood filter to...


Aug 08, 2016, 08:30 ET CytoSorbents Awarded $650,000 in SBIR Grant Contracts to Continue Development of Novel Hemocompatible Potassium Binding Polymers

 CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy company specializing in the purification of blood and bodily fluids,...


Aug 02, 2016, 07:00 ET CytoSorbents to Report Q2 2016 Operating and Financial Results

 CytoSorbents Corporation (CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification filter to treat...


Jul 13, 2016, 08:00 ET CytoSorbents Teams with Medial and Meditrade to Bring CytoSorb® to Hungary, Czech Republic, Slovakia, and Poland

 CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its flagship CytoSorb® blood filter to...